UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD

Neuropsychopharmacology (New York, N.Y.), 2013-02, Vol.38 (3), p.405-413

2013

Volltextzugriff (PDF)

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of alpha 4 beta 2 Agonist ABT-894 in Adults with ADHD

Neuropsychopharmacology (New York, N.Y.), 2013-02, Vol.38 (3), p.405-413

2013

Volltextzugriff (PDF)

The scopolamine model as a pharmacodynamic marker in early drug development

Psychopharmacologia, 2012-03, Vol.220 (1), p.97-107

2012

Volltextzugriff (PDF)

A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

Journal of the American Academy of Child and Adolescent Psychiatry, 2009-05, Vol.48 (5), p.519-532

2009

Volltextzugriff (PDF)

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

The international journal of neuropsychopharmacology, 2010-04, Vol.13 (3), p.273-287

2010

Volltextzugriff (PDF)

Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials

Journal of the American Academy of Child and Adolescent Psychiatry, 2011-01, Vol.50 (1), p.73-84.e1

2011

Volltextzugriff (PDF)

Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease

Alzheimer disease and associated disorders, 2015-07, Vol.29 (3), p.192-199

2015

Volltextzugriff (PDF)

A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder

The journal of clinical psychiatry, 2012-06, Vol.73 (6), p.783

2012

Volltextzugriff (PDF)

A Phonology of Italian in a Generative Grammar

Saltarelli, Mario

Reprint 2011., 2011

Volltextzugriff (PDF)

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Headache, 2008-07, Vol.48 (7), p.1012-1025

2008

Volltextzugriff (PDF)

Sevoflurane Formulation Water Content Influences Degradation by Lewis Acids in Vaporizers

Anesthesia and analgesia, 2009-06, Vol.108 (6), p.1796-1802

2009

Volltextzugriff (PDF)

Diachronic Studies in Romance Linguistics

Mario Saltarelli, Dieter Wanner / Mario Saltarelli, Dieter Wanner

2010

Volltextzugriff (PDF)

Suicidality and divalproex sodium: analysis of controlled studies in multiple indications

Annals of general psychiatry, 2011-01, Vol.10 (1), p.1-1

2011

Volltextzugriff (PDF)

Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study

Headache, 2009-01, Vol.49 (1), p.45-53

2009

Volltextzugriff (PDF)

Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

Psychopharmacologia, 2012-02, Vol.219 (3), p.715-725

2012

Volltextzugriff (PDF)

Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches: Results of an Open-Label Extension Trial in Adolescents

Headache, 2009-01, Vol.49 (1), p.36-44

2009

Volltextzugriff (PDF)

Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study

Pediatric neurology, 2009-08, Vol.41 (2), p.101-110

2009

Volltextzugriff (PDF)

On language unity and disunity

Forum italicum, 2014-08, Vol.48 (2), p.188-201

Saltarelli, Mario

2014

Volltextzugriff (PDF)

A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia

Journal of clinical psychopharmacology, 2011-04, Vol.31 (2), p.221-225

2011

Volltextzugriff (PDF)

ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P325-P325

2009

Volltextzugriff (PDF)

ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors

Alzheimer's & dementia, 2009-07, Vol.5 (4), p.P157-P157

2009

Volltextzugriff (PDF)

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

Blood, 2016-12, Vol.128 (22), p.1265-1265

2016

Volltextzugriff (PDF)

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania

The journal of clinical psychiatry, 2006-10, Vol.67 (10), p.1501-1510

2006

Volltextzugriff (PDF)

Diachronic Studies in Romance Linguistics: Papers presented at a Conference on Diachronic Romance Linguistics, University of Illinois, April 1972

Reprint 2010., 2010

Volltextzugriff (PDF)

Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

Neuropsychopharmacology (New York, N.Y.), 2009-04, Vol.34 (5), p.1330-1338

2009

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(114)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(125)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Language & Linguistics
(35)
Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Humans
(26)
Male
(23)
Biological And Medical Sciences
(21)
Female
(19)
Medical Sciences
(19)
Language Teaching & Learning Material & Coursework
(18)
Adult
(13)
Phonetics, Phonology, Prosody
(13)
Middle Aged
(12)
Neurosciences & Neurology
(12)
Pharmacology. Drug Treatments
(12)
Adolescent
(11)
Double-Blind Method
(11)
Neuropharmacology
(9)
Psychiatry
(9)
Aged
(8)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of α4β2 Agonist ABT-894 in Adults with ADHD

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of alpha 4 beta 2 Agonist ABT-894 in Adults with ADHD

The scopolamine model as a pharmacodynamic marker in early drug development

A Double-Blind, Randomized, Placebo-Controlled Trial of Divalproex Extended-Release in the Treatment of Bipolar Disorder in Children and Adolescents

Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925

Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials

Adaptive, Dose-finding Phase 2 Trial Evaluating the Safety and Efficacy of ABT-089 in Mild to Moderate Alzheimer Disease

A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder

A Phonology of Italian in a Generative Grammar

Divalproex Extended-Release in Adolescent Migraine Prophylaxis: Results of a Randomized, Double-Blind, Placebo-Controlled Study

Sevoflurane Formulation Water Content Influences Degradation by Lewis Acids in Vaporizers

Diachronic Studies in Romance Linguistics

Suicidality and divalproex sodium: analysis of controlled studies in multiple indications

Divalproex Sodium Extended-Release for the Prophylaxis of Migraine Headache in Adolescents: Results of a Stand-Alone, Long-Term Open-Label Safety Study

Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study

Safety and Tolerability of Divalproex Sodium Extended-Release in the Prophylaxis of Migraine Headaches: Results of an Open-Label Extension Trial in Adolescents

Divalproex Sodium in Children with Partial Seizures: 12-Month Safety Study

On language unity and disunity

A double-blind, randomized, placebo-controlled study of the dopamine D₃ receptor antagonist ABT-925 in patients with acute schizophrenia

ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects

ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors

ANX005, an Inhibitory Antibody Against C1q, Blocks Complement Activation Triggered By Cold Agglutinins in Human Disease

A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania

Diachronic Studies in Romance Linguistics: Papers presented at a Conference on Diachronic Romance Linguistics, University of Illinois, April 1972

Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia

Suchergebnisse filtern